ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiology"

  • Abstract Number: 0594 • ACR Convergence 2021

    The Burden of Systemic Lupus in Five Distinct Racial and Ethnic Groups in Israel: A Population-based Study

    Titilola Falasinnu1, Nada Rizk1, Becca Feldman2, Devy Zisman3, Michael Leshchinsky2, Gabriella Lawrence2, Yashaar Chaichian4 and Julia Simard1, 1Stanford School of Medicine, Stanford, CA, 2Clalit Research Institute, Clalit Health Services, Ramat Gan, Israel, 3Carmel Medical Center, Haifa, Israel, 4Stanford University, Los Gatos, CA

    Background/Purpose: Misclassification of race and ethnicity in data can impact how disparities in prevalence, incidence, severity, and complications of systemic lupus erythematosus (SLE) are interpreted.…
  • Abstract Number: 0991 • ACR Convergence 2021

    Does Diet Affect Gout Risk Differently Among Genetically Predisposed Women?: Prospective Female Cohort Study Findings over 34 Years

    Chio Yokose1, Natalie McCormick2, Na Lu3, Amit Joshi2 and Hyon K. Choi4, 1Massachusetts General Hospital, Waltham, MA, 2Massachusetts General Hospital, Boston, MA, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Massachusetts General Hospital, Lexington, MA

    Background/Purpose: Gout has long been considered a male disease. However, several recent analyses of the Global Burden of Disease (GBD) Study report a disproportionate worsening…
  • Abstract Number: 1292 • ACR Convergence 2021

    Systemic Lupus Erythematous Readmissions Has Reduced in the Last Decade in the United States: A 9- year Longitudinal Study of the Nationwide Readmission Database

    Ehizogie Edigin1, Precious Eseaton2, Chinenye Osuorji3, Ajayi Temitope4, Oluwafeyi Adedoyin5, Nneka Chukwu6 and Augustine Manadan7, 1Internal Medicine, John H Stroger Jr. Hospital of Cook County, Chicago, IL, 2University of Benin, Benin, Nigeria, 3Internal Medicine, Burrell College of Osteopathic Medicine, Las Cruces, NM, 4Internal Medicine, University of Buffalo, Buffalo, NY, 5Internal Medicine, Englewood Hospital and Medicine Center, Englewood, NJ, 6Nuvance Health Internal Medicine Residency, Poughkeepsie, NY, 7Rush University Medical Center, Chicago, IL

    Background/Purpose: Longitudinal data on trends of Systemic Lupus Erythematous (SLE) readmissions is scarce. Our study aims to study trends of 30-day readmissions of patients admitted…
  • Abstract Number: 1787 • ACR Convergence 2021

    What Is Peripheral SpondyloArthritis? Identifying Disease Phenotype and Burden: A Post Hoc Analysis of the ASAS-PerSpA International Study

    Nelly Ziade1, Joe Rassi2, Bassel Elzorkany3, Clementina López Medina4, Sherif Gamal3, Sani Hlais5, Maxime Dougados6 and Xenofon Baraliakos7, 1Rheumatology Department, Saint-Joseph Medical University and Hotel-Dieu de France Hospital, Beirut, Lebanon, 2Department of Orthopedic Surgery, Hotel-Dieu de France, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon, 3Cairo University, Cairo, Egypt, Cairo, Egypt, 4Department of Rheumatology, Reina Sofia Hospital, IMIBIC, University of Cordoba, Cordoba, Spain/ Department of Rheumatology, University of Paris, Cochin Hospital, Paris, France, 5Department of Family Medicine, American University of Beirut/ Saint-Joseph University, Beirut, Lebanon, 6Université de Paris . Department of Rheumatology - Hôpital Cochin. Assistance Publique - Hôpitaux de Paris . INSERM (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité. Paris, France., Paris, France, 7Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany

    Background/Purpose: Peripheral spondyloarthritis (pSpA) shows features that overlap with psoriatic arthritis (PsA), axial spondyloarthritis (axSpA) and other forms of SpA and is unsatisfactorily defined despite…
  • Abstract Number: 0263 • ACR Convergence 2021

    Patterns of Medication Switching in Juvenile Idiopathic Arthritis: A Retrospective Analysis of a National Administrative Claims Database

    Mei-Sing Ong1, Sarah Ringold2, Melissa Mannion3, Marc Natter4, Laura Schanberg5 and Yukiko Kimura6, 1Harvard Medical School & Harvard Pilgrim Healthcare Institute, Boston, MA, 2Seattle Children's Hospital, Seattle, WA, 3University of Alabama at Birmingham, Birmingham, AL, 4Boston Children's Hospital, Boston, MA, 5Duke University Medical Center, Durham, NC, 6Hackensack University Medical Center, New York, NY

    Background/Purpose: Although the increasing availability of biologic disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic DMARDs (tsDMARDs) has significantly improved outcomes for patients with Juvenile Idiopathic…
  • Abstract Number: 0562 • ACR Convergence 2021

    Inpatient Epidemiology and Resource Utilization of Ankylosing Spondylitis: National Inpatient Sample 2018

    Patompong Ungprasert1, Thanat Chaikijurajai2, Karn Wijarnpreecha3 and Paul Kroner3, 1Cleveland Clinic, Cleveland Heights, OH, 2Cleveland Clinic, Cleveland, OH, 3Mayo Clinic Florida, Jacksonville, FL

    Background/Purpose: Little is known about inpatient epidemiology, economic burden and resource utilization of patients with ankylosing spondylitis (AS). The current study aims to describe those…
  • Abstract Number: 0596 • ACR Convergence 2021

    Racial Disparities in US Adults with Systemic Lupus Erythematosus: Prevalence, Quality of Life, Comorbidities and Healthcare Costs

    Shannon Grabich1, Cullen Seal2, Robert Ortmann3 and Sandra Sze-jung Wu4, 1Xcenda, Durham, NC, 2Xcenda, Carrollton, TX, 3AstraZeneca, Greenwood, IN, 4AstraZeneca, Wilmington, DE

    Background/Purpose: SLE is a chronic, multisystem autoimmune disease characterized by reoccurring flares and remissions. It is more common among Asian, Black, and Hispanic populations. Racial…
  • Abstract Number: 1022 • ACR Convergence 2021

    Incidence of Antisynthetase Syndrome and Risk of Malignancy in a Population-based Cohort (1998-2019)

    Caitrin Coffey1, Li Wang1, Stephanie Duong1, Cassondra Hulshizer1, Cynthia Crowson2, Jay Ryu1 and Floranne Ernste1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Eyota, MN

    Background/Purpose: The antisynthetase syndrome (ASSD) is a distinct subgroup of the idiopathic inflammatory myopathies characterized by myositis, interstitial lung disease, inflammatory arthritis, Raynaud’s phenomenon and…
  • Abstract Number: 1304 • ACR Convergence 2021

    Increased Risk of Vertebral Fracture Among Patients with Psoriatic Arthritis: A Systematic Review and Meta-analysis

    Patompong Ungprasert1, Nipith Charoenngam2, Ben Ponvilawan3, Jerapas Thongpiya4 and Pitchaporn Yingchoncharoen3, 1Cleveland Clinic, Cleveland Heights, OH, 2Mount Auburn Hospital, Boston, MA, 3Mahidol University, Bangkok, Thailand, 4Mahdiol University, Bangkok, Thailand

    Background/Purpose: Increased risk of vertebral fracture (VF) has been documented in several autoimmune diseases as a result of excessive inflammatory burden and use of corticosteroids.…
  • Abstract Number: 1865 • ACR Convergence 2021

    Incidence, Prevalence, and Mortality of Chronic Periaortitis: A Population-based Study

    Umar Ghaffar1, Kenneth Warrington2, Stephanie Duong1, Cynthia Crowson3, Michelle Burke1, Boyd Viers1, Aaron Potretzke1, Haraldur Bjarnason1 and Matthew Koster1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, Minnesota, 3Mayo Clinic, Eyota, MN

    Background/Purpose: Chronic periaortitis is an inflammatory condition that typically involves the infrarenal portion of the abdominal aorta. To date, no epidemiologic studies have been performed…
  • Abstract Number: L02 • ACR Convergence 2020

    Risk Mitigating Behavior in People with Rheumatic Diseases or Psoriasis During the COVID-19 Pandemic Differ by Immunosuppressant Treatment Type: A Patient survey Study

    Mark Yates1, Satveer Mahil1, Sinead Langan2, Claudia De la cruz3, Paola diMeglio1, Nick Dand1, Zenas Yiu4, Kayleigh Mason4, Teresa Tsakok1, Freya Meynall5, Helen McAteer6, John Weinman1, Paolo Gisondi7, Luis Puig Sanz8, Richard Warren4, Francesca Capon1, Jullien Denis9, Tiago Torres10, Chris Griffiths4, Jonathan Barker1, Kimme Hyrich4, Andrew Cope1, Ian Bruce4, Iain McInnes11, Raj Sengupta12, Helena Marzo-Ortega13, Matthew Brown1, James Galloway1 and Catherine Smith1, 1King's College London, London, United Kingdom, 2London School of Hygiene and Tropical Medicine, London, United Kingdom, 3University of Santiago, Santiago, Chile, 4University of Manchester, Manchester, United Kingdom, 5Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom, 6Psoriasis Association, London, United Kingdom, 7University of Verona, Verona, Italy, 8Hospital de la Santa Creu I Sant Pau, Barcelona, Spain, 9Hospices Civils de Lyon, Lyon, France, 10University of Porto, Porto, Portugal, 11University of Glasgow, Glasgow, United Kingdom, 12Royal United Hospitals Bath, Bath, United Kingdom, 13University of Leeds, Leeds, United Kingdom

    Background/Purpose: Clinician-reported registry data suggest that use of biologics in people with immune-mediated inflammatory diseases (IMIDs) is associated with a lower risk of adverse COVID-19…
  • Abstract Number: 0055 • ACR Convergence 2020

    Racial and Sex-based Disparities in Health Care Utilization: Eye Inflammation as a Paradigm

    Krati Chauhan1 and James Rosenbaum2, 1Southern Illinois University - School of Medicine, Springfield, IL, 2Oregon Health & Science University, Portland, OR

    Background/Purpose: Disparities in health care utilization based on sex, race, education, or income affect outcomes in rheumatologic care. We have used ocular inflammatory and infectious…
  • Abstract Number: 0525 • ACR Convergence 2020

    Epidemiology of Thromboembolic Complications Among Hospitalized Patients with Antiphospholipid Syndrome in the United States

    Lauren Mathias1, Aditya Mantha2, Kristen Mathias3 and Glenn Ehresmann1, 1University of Southern California, Division of Rheumatology, Los Angeles, CA, 2University of Southern California, Department of Medicine, Los Angeles, CA, 3University of Chicago, Department of Medicine, Chicago, IL

    Background/Purpose: Antiphospholipid syndrome (APLS) is characterized by arterial and venous thrombosis, often in the setting of an underlying systemic disease. Few studies have described the…
  • Abstract Number: 0593 • ACR Convergence 2020

    Patient Characteristics and Factors Affecting Decision-Making Regarding Total Knee Replacement by Different Types of Physicians Treating Patients with Knee OA

    Angela Bedenbaugh1, Vinson Lee1, Gary Oderda2, Sarah Kennedy1, Jeyanesh Tambiah1, Diana Brixner2 and Timothy McAlindon3, 1Samumed, LLC, San Diego, CA, 2University of Utah, Salt Lake City, UT, 3Tufts Medical Center, Boston, MA

    Background/Purpose: Total knee replacement (TKR) is considered an effective knee OA treatment and is a commonly performed orthopedic procedure that relieves pain and improves function and…
  • Abstract Number: 1005 • ACR Convergence 2020

    Risk of Non-vertebral Fractures Among Rheumatoid Arthritis Patients Treated with Biologic or Targeted-Synthetic DMARDs: A Multi-Database Comparative Safety Study

    Ajinkya Pawar1, Rishi Desai1, Mengdong He1, Lily Bessette1 and Seoyoung Kim2, 1Brigham and Women's hospital, Boston, 2Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Rheumatoid arthritis (RA) increases risk of osteoporosis and fractures. However, limited head-to-head comparative data exists on the risk of non-vertebral osteoporotic fractures (NVFs) among…
  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 46
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology